US7294754B2
(en)
|
2004-10-19 |
2007-11-13 |
Regeneron Pharmaceuticals, Inc. |
Method for generating an animal homozygous for a genetic modification
|
US7740159B2
(en)
*
|
2006-08-02 |
2010-06-22 |
Ethicon Endo-Surgery, Inc. |
Pneumatically powered surgical cutting and fastening instrument with a variable control of the actuating rate of firing with mechanical power assist
|
US20090271884A1
(en)
*
|
2008-03-07 |
2009-10-29 |
Regeneron Pharmaceuticals, Inc. |
ES Cell-Derived Mice From Diploid Host Embryo Injection
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
WO2011158009A1
(en)
|
2010-06-17 |
2011-12-22 |
Kymab Limited |
Animal models and therapeutic molecules
|
DK2517557T4
(da)
|
2009-07-08 |
2023-09-25 |
Kymab Ltd |
Dyremodeller og terapeutiske molekyler
|
US20120204278A1
(en)
|
2009-07-08 |
2012-08-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
WO2011020014A1
(en)
|
2009-08-14 |
2011-02-17 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
ES2700852T3
(es)
|
2009-10-06 |
2019-02-19 |
Regeneron Pharma |
Ratones modificados genéticamente e injerto
|
ES2595376T3
(es)
|
2009-12-10 |
2016-12-29 |
Regeneron Pharmaceuticals, Inc. |
Ratones que producen anticuerpos de cadena pesada
|
SG10201408415PA
(en)
|
2009-12-21 |
2015-01-29 |
Regeneron Pharma |
HUMANIZED FCγ R MICE
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
HUE029785T2
(en)
|
2010-02-08 |
2017-04-28 |
Regeneron Pharma |
Common mouse light chain
|
EP2579711B1
(en)
|
2010-06-11 |
2019-04-17 |
Regeneron Pharmaceuticals, Inc. |
Production of fertile xy female animals from xy es cells
|
BR112012033248A2
(pt)
|
2010-06-22 |
2017-11-28 |
Regeneron Pharma |
camundongos expressando uma cadeia leve com variável de lâmbda humana e regiões constantes de camundongo
|
US10793829B2
(en)
|
2010-07-26 |
2020-10-06 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
KR20130097156A
(ko)
|
2010-07-26 |
2013-09-02 |
트리아니, 인코포레이티드 |
트랜스제닉 동물 및 이의 사용 방법
|
US10662256B2
(en)
|
2010-07-26 |
2020-05-26 |
Trianni, Inc. |
Transgenic mammals and methods of use thereof
|
EP2601298B1
(en)
|
2010-08-02 |
2016-11-30 |
Regeneron Pharmaceuticals, Inc. |
Mice that make binding proteins comprising vl domains
|
WO2012092284A1
(en)
|
2010-12-27 |
2012-07-05 |
The Jackson Laboratory |
Compositions and methods relating to non-human animals modified to promote production of selected gametes
|
SG10202008003VA
(en)
|
2011-02-15 |
2020-10-29 |
Regeneron Pharma |
Humanized m-csf mice
|
DE14176593T1
(de)
|
2011-02-25 |
2015-03-05 |
Regeneron Pharmaceuticals, Inc. |
ADAM6 Mäuse
|
PT2631654E
(pt)
|
2011-05-12 |
2015-08-21 |
Regeneron Pharma |
Ensaio de libertação de neuropéptidos para canais de sódio
|
WO2012168399A1
(en)
|
2011-06-08 |
2012-12-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting, treating and modelling hormone resistance
|
PL3572517T3
(pl)
|
2011-08-05 |
2021-10-04 |
Regeneron Pharmaceuticals, Inc. |
Myszy z humanizowanym uniwersalnym łańcuchem lekkim
|
EP3839049A3
(en)
|
2011-09-19 |
2021-10-20 |
Kymab Limited |
Antibodies, variable domains & chains tailored for human use
|
WO2013045916A1
(en)
|
2011-09-26 |
2013-04-04 |
Kymab Limited |
Chimaeric surrogate light chains (slc) comprising human vpreb
|
US9591835B2
(en)
|
2011-10-28 |
2017-03-14 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex animals
|
KR102148387B1
(ko)
|
2011-10-28 |
2020-08-26 |
리제너론 파아마슈티컬스, 인크. |
유전자 변형된 t 세포 수용체 마우스
|
RS53683B1
(en)
|
2011-10-28 |
2015-04-30 |
Regeneron Pharmaceuticals Inc. |
HUMANIZOVANI IL-6 I IL-6 RECEPTOR
|
RU2660564C2
(ru)
|
2011-10-28 |
2018-07-06 |
Регенерон Фармасьютикалз, Инк. |
Генетически модифицированные мыши, экспрессирующие химерные молекулы главного комплекса гистосовместимости
|
LT3262932T
(lt)
|
2011-10-28 |
2019-08-26 |
Regeneron Pharmaceuticals, Inc. |
Pelės su genetiškai modifikuotu pagrindiniu histosuderinamumo kompleksu
|
US9043996B2
(en)
|
2011-10-28 |
2015-06-02 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex animals
|
EP2773323A4
(en)
|
2011-10-31 |
2015-04-22 |
Merck Sharp & Dohme |
NANO-SUSPENSION METHOD
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
LT2793567T
(lt)
|
2011-12-20 |
2019-04-10 |
Regeneron Pharmaceuticals, Inc. |
Humanizuotos lengvosios grandinės pelės
|
US10036030B2
(en)
|
2011-12-22 |
2018-07-31 |
E I Du Pont De Nemours And Company |
Use of the soybean sucrose synthase promoter to increase plant seed lipid content
|
ME03611B
(me)
|
2012-02-01 |
2020-07-20 |
Regeneron Pharma |
Humanizovani miševi koji eksprimiraju teške lance koji sadrže vl domene
|
NZ630637A
(en)
|
2012-03-06 |
2016-09-30 |
Regeneron Pharma |
Common light chain mouse
|
CA2865645A1
(en)
|
2012-03-16 |
2013-09-19 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals expressing immunoglobulin sequences ph-sensitive for antigen building
|
LT3348140T
(lt)
|
2012-03-16 |
2021-01-25 |
Regeneron Pharmaceuticals, Inc. |
Histidinu pakeisti lengvosios grandinės antikūnai ir genetiškai modifikuoti graužikai, išvesti jų gamybai
|
MY173376A
(en)
|
2012-03-16 |
2020-01-21 |
Regeneron Pharma |
Mice that produce antigen?binding proteins with ph?dependent binding characteristics
|
US20140013456A1
(en)
|
2012-03-16 |
2014-01-09 |
Regeneron Pharmaceuticals, Inc. |
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
CN109536526B
(zh)
|
2012-04-25 |
2020-06-09 |
瑞泽恩制药公司 |
核酸酶介导的使用大靶向载体的靶向
|
EP2858487B1
(en)
|
2012-06-12 |
2019-10-23 |
Regeneron Pharmaceuticals, Inc. |
Humanized non-human animals with restricted immunoglobulin heavy chain loci
|
JP6283031B2
(ja)
|
2012-09-07 |
2018-02-21 |
イエール ユニバーシティ |
遺伝学的に修飾された非ヒト動物およびその使用法
|
CN114766432A
(zh)
|
2012-11-05 |
2022-07-22 |
再生元制药公司 |
经遗传修饰的非人动物及其使用方法
|
ES2904803T3
(es)
|
2013-02-20 |
2022-04-06 |
Regeneron Pharma |
Modificación genética de ratas
|
AU2014218897C1
(en)
|
2013-02-20 |
2019-03-07 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing humanized T-cell co-receptors
|
US20150342163A1
(en)
|
2013-02-22 |
2015-12-03 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex mice
|
LT2958937T
(lt)
|
2013-02-22 |
2018-11-26 |
Regeneron Pharmaceuticals, Inc. |
Pelė, ekspresuojanti humanizuotą audinių dermės kompleksą
|
KR102309653B1
(ko)
|
2013-03-11 |
2021-10-08 |
리제너론 파아마슈티컬스, 인크. |
키메라 주요 조직적합성 복합체 (mhc) 제ii부류 분자를 발현하는 유전자전이 마우스
|
WO2014164640A1
(en)
|
2013-03-11 |
2014-10-09 |
Regeneron Pharmaceuticals, Inc. |
Transgenic mice expressing chimeric major histocompatibility complex (mhc) class i molecules
|
HRP20230490T1
(hr)
|
2013-03-13 |
2023-08-04 |
Regeneron Pharmaceuticals, Inc. |
Miševi koji izražavaju ograničeni repertoar lakog lanca imunoglobulina
|
KR20150126863A
(ko)
|
2013-03-13 |
2015-11-13 |
리제너론 파마슈티칼스 인코포레이티드 |
공통 경쇄 마우스
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
ES2699578T3
(es)
*
|
2013-04-16 |
2019-02-11 |
Regeneron Pharma |
Modificación direccionada del genoma de rata
|
JP6689498B2
(ja)
*
|
2013-04-16 |
2020-04-28 |
イーエムべーアー−インスティツート フューア モレクラー ビオテクノロギー ゲーエムベーハー |
ブラストイド、細胞株に基づく人工胚盤胞
|
US9783593B2
(en)
|
2013-05-02 |
2017-10-10 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
US11707056B2
(en)
|
2013-05-02 |
2023-07-25 |
Kymab Limited |
Animals, repertoires and methods
|
US9554564B2
(en)
|
2013-08-07 |
2017-01-31 |
Regeneron Pharmaceuticals, Inc. |
IncRNA-knockout mice
|
KR20200103882A
(ko)
|
2013-09-18 |
2020-09-02 |
리제너론 파마슈티칼스 인코포레이티드 |
히스티딘 엔지니어링된 경쇄 항체 및 그것을 생성하기 위한 유전자 변형된 비-인간 동물
|
DK3175706T3
(en)
|
2013-09-23 |
2019-03-04 |
Regeneron Pharma |
Non-human animals with a humanized signal regulatory protein gene
|
EP3051942B1
(en)
|
2013-10-01 |
2020-09-02 |
Kymab Limited |
Animal models and therapeutic molecules
|
HUE055766T2
(hu)
|
2013-11-07 |
2021-12-28 |
Ozgene Holdings Pty Ltd |
Készítmények és eljárások genetikailag módosított állatok elõállítására
|
SG10201900003WA
(en)
|
2013-11-19 |
2019-02-27 |
Regeneron Pharma |
Non-human animals having a humanized b-cell activating factor gene
|
US20150143559A1
(en)
|
2013-11-19 |
2015-05-21 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a humanized a proliferation-inducing ligand gene
|
PT3080279T
(pt)
|
2013-12-11 |
2018-12-17 |
Regeneron Pharma |
Métodos e composições para a modificação direcionada de um genoma
|
KR102170502B1
(ko)
|
2013-12-11 |
2020-10-28 |
리제너론 파마슈티칼스 인코포레이티드 |
게놈의 표적화된 변형을 위한 방법 및 조성물
|
EP3895528A1
(en)
|
2014-03-21 |
2021-10-20 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that make single domain binding proteins
|
CN106164092A
(zh)
|
2014-03-21 |
2016-11-23 |
瑞泽恩制药公司 |
表现不同结合特征的vl抗原结合蛋白
|
MX2016014504A
(es)
|
2014-05-05 |
2017-05-23 |
Regeneron Pharma |
Animales c5 y c3 humanizados.
|
NO2785538T3
(sl)
|
2014-05-07 |
2018-08-04 |
|
|
KR20240017405A
(ko)
|
2014-05-19 |
2024-02-07 |
리제너론 파마슈티칼스 인코포레이티드 |
인간 epo를 발현하는 유전자 변형된 비-인간 동물
|
CN106413394B
(zh)
|
2014-05-30 |
2020-02-11 |
再生元制药公司 |
人源化二肽基肽酶iv(dpp4)动物
|
LT3152312T
(lt)
|
2014-06-06 |
2020-04-27 |
Regeneron Pharmaceuticals, Inc. |
Tikslinio lokuso modifikavimo būdai ir kompozicijos
|
MX2016016903A
(es)
|
2014-06-19 |
2017-03-27 |
Regeneron Pharma |
Animales no humanos que tienen un gen de muerte celular programada 1 humanizado.
|
PL3161128T3
(pl)
|
2014-06-26 |
2019-02-28 |
Regeneron Pharmaceuticals, Inc. |
Sposoby i kompozycje do celowanych modyfikacji genetycznych i sposoby zastosowania
|
US20160081314A1
(en)
|
2014-09-19 |
2016-03-24 |
Regeneron Pharmaceuticals, Inc. |
Chimeric Antigen Receptors
|
AU2015332451A1
(en)
|
2014-10-15 |
2017-04-20 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for generating or maintaining pluripotent cells
|
US10457960B2
(en)
|
2014-11-21 |
2019-10-29 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modification using paired guide RNAs
|
HUE059417T2
(hu)
|
2014-11-24 |
2022-11-28 |
Regeneron Pharma |
Humanizált CD3-komplexet expresszáló nem humán állatok
|
MX2017007293A
(es)
|
2014-12-05 |
2018-03-12 |
Regeneron Pharma |
Animales no humanos que tienen un gen del grupo de diferenciacion 47 humanizado.
|
MX2017007636A
(es)
|
2014-12-09 |
2018-03-28 |
Regeneron Pharma |
Animales no humanos que tienen un gen del grupo de diferenciacion 274 humanizado.
|
MX2017008190A
(es)
|
2014-12-19 |
2018-03-23 |
Regeneron Pharma |
Metodos y composiciones para la modificacion genetica dirigida a traves de direccionamiento multiple de una sola etapa.
|
BR112017019620A2
(pt)
|
2015-03-16 |
2018-05-15 |
Regeneron Pharmaceuticals, Inc. |
?roedor geneticamente modificado, célula ou tecido, métodos para produção de um roedor geneticamente modificado e de uma população de neurônios motores, métodos para seleção de um agente candidato para modular a disfunção neuronal motora e de um agente candidato para redução do estresse oxidativo em um neurônio motor, ácido nucleico, e, célula de roedor?
|
CN107438622A
(zh)
|
2015-03-19 |
2017-12-05 |
瑞泽恩制药公司 |
选择结合抗原的轻链可变区的非人动物
|
HUE064168T2
(hu)
|
2015-04-06 |
2024-02-28 |
Regeneron Pharma |
Humanizált T-sejt által közvetített immunválaszok nem humán állatokban
|
CN115943929A
(zh)
|
2015-04-13 |
2023-04-11 |
再生元制药公司 |
人源化SIRPα-IL15敲入小鼠及其使用方法
|
AU2016270587B2
(en)
|
2015-05-29 |
2020-12-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a disruption in a C9ORF72 locus
|
WO2016205523A1
(en)
|
2015-06-16 |
2016-12-22 |
The Jackson Laboratory |
Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
|
CN108135151A
(zh)
|
2015-09-02 |
2018-06-08 |
瑞泽恩制药公司 |
前列腺癌的啮齿动物模型
|
US10893666B2
(en)
|
2015-09-17 |
2021-01-19 |
Regeneron Pharmaceuticals, Inc. |
Production of fertile XY female animals by silencing of genes on the Y chromosome
|
NZ742447A
(en)
|
2015-11-20 |
2022-12-23 |
Regeneron Pharma |
Non-human animals having a humanized lymphocyte-activation gene 3
|
WO2017095939A1
(en)
|
2015-12-03 |
2017-06-08 |
Trianni, Inc. |
Enhanced immunoglobulin diversity
|
IL260743B2
(en)
|
2016-02-04 |
2024-03-01 |
Trianni Inc |
Advanced production of antibodies
|
JP6843872B2
(ja)
|
2016-02-04 |
2021-03-17 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
操作されたangptl8遺伝子を有する非ヒト動物
|
RU2018130010A
(ru)
|
2016-02-16 |
2020-03-17 |
Регенерон Фармасьютикалз, Инк. |
Животные, отличные от человека, имеющие мутантный ген кинурениназы
|
SG10202001578RA
(en)
|
2016-02-29 |
2020-04-29 |
Regeneron Pharma |
Rodents having a humanized tmprss gene
|
EP3457840B1
(en)
|
2016-05-20 |
2024-04-10 |
Regeneron Pharmaceuticals, Inc. |
Methods for breaking immunological tolerance using multiple guide rnas
|
WO2017210586A1
(en)
|
2016-06-03 |
2017-12-07 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
|
JP2019523009A
(ja)
|
2016-07-29 |
2019-08-22 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
C末端切断型フィブリリン−1の発現をもたらす変異を有するマウス
|
KR20190038613A
(ko)
|
2016-08-11 |
2019-04-08 |
더 잭슨 래보라토리 |
유전자 변형된 면역결핍 비-인간 동물에서의 개선된 인간 적혈구 생존에 관한 방법 및 조성물
|
JP7026678B2
(ja)
|
2016-09-30 |
2022-02-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
C9orf72座位中にヘキサヌクレオチドリピート伸長を有する非ヒト動物
|
JP2020500014A
(ja)
|
2016-10-27 |
2020-01-09 |
ザ ジャクソン ラボラトリーThe Jackson Laboratory |
ヒト肝細胞異種移植のための遺伝子改変マウス
|
JP7458185B2
(ja)
|
2016-11-30 |
2024-03-29 |
ザ ジャクソン ラボラトリー |
改善されたヒト自然免疫細胞の発生を有するヒト化マウスモデル
|
SG11201906540WA
(en)
|
2017-01-19 |
2019-08-27 |
Open Monoclonal Tech Inc |
Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
|
CA3053386A1
(en)
|
2017-02-27 |
2018-08-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animal models of retinoschisis
|
WO2018175581A1
(en)
|
2017-03-21 |
2018-09-27 |
The Jackson Laboratory |
A GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 MOUSE Trem2.p.R47H AND METHODS OF USE THEREOF
|
JP7129426B2
(ja)
|
2017-05-12 |
2022-09-01 |
ザ ジャクソン ラボラトリー |
Mhcクラスiおよびmhcクラスiiを欠損しているnsgマウス
|
JP7278978B2
(ja)
|
2017-06-27 |
2023-05-22 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒト化asgr1座位を含む非ヒト動物
|
US11021719B2
(en)
|
2017-07-31 |
2021-06-01 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
|
RU2019143568A
(ru)
|
2017-07-31 |
2021-09-02 |
Регенерон Фармасьютикалс, Инк. |
Способы и композиции для оценки crispr/cas-индуцированной рекомбинации с экзогенной донорной нуклеиновой кислотой in vivo
|
BR112020001364A2
(pt)
|
2017-07-31 |
2020-08-11 |
Regeneron Pharmaceuticals, Inc. |
métodos para testar e modificar a capacidade de uma crispr/cas nuclease.
|
JP7404237B2
(ja)
|
2017-08-09 |
2023-12-25 |
ザ ジャクソン ラボラトリー |
ヒトインターロイキン15を発現する免疫不全マウス
|
PT3687287T
(pt)
|
2017-09-29 |
2023-11-03 |
Regeneron Pharma |
Roedores que expressam complexo c1q humanizado
|
US20190098879A1
(en)
|
2017-09-29 |
2019-04-04 |
Regeneron Pharmaceuticals, Inc. |
Non-Human Animals Comprising A Humanized TTR Locus And Methods Of Use
|
AU2018366290B2
(en)
|
2017-11-10 |
2022-01-27 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising Slc30a8 mutation and methods of use
|
CA3076377A1
(en)
|
2017-11-30 |
2019-06-06 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized trkb locus
|
JP7334178B2
(ja)
|
2018-03-19 |
2023-08-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
CRISPR/Cas系を使用した動物での転写モジュレーション
|
CN116514959A
(zh)
|
2018-03-24 |
2023-08-01 |
瑞泽恩制药公司 |
用于产生针对肽-mhc复合物的治疗性抗体的经过基因修饰的非人动物、其制造方法和用途
|
JP7328243B2
(ja)
|
2018-03-26 |
2023-08-16 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
治療薬を試験するためのヒト化げっ歯類
|
US10463029B1
(en)
|
2018-06-07 |
2019-11-05 |
Regeneron Pharmaceuticals, Inc. |
Rodent model of steel syndrome
|
WO2019241350A1
(en)
|
2018-06-13 |
2019-12-19 |
Regeneron Pharmaceuticals, Inc. |
A rodent model of fibrodysplasia ossificans progressiva
|
US20210195879A1
(en)
|
2018-06-21 |
2021-07-01 |
The Jackson Laboratory |
Genetically modified mouse models of alzheimer's disease
|
CA3098040A1
(en)
|
2018-07-16 |
2020-01-23 |
Regeneron Pharmaceuticals, Inc. |
Non-human animal models of ditra disease and uses thereof
|
CA3112612C
(en)
|
2018-09-13 |
2024-02-27 |
Regeneron Pharmaceuticals, Inc. |
Complement factor h gene knockout rat as a model of c3 glomerulopathy
|
CN113195532A
(zh)
|
2018-12-18 |
2021-07-30 |
瑞泽恩制药公司 |
使用针对瘦素受体、gdf8和活化素a的拮抗剂增加体重和瘦肌肉质量的组合物和方法
|
JP7449291B2
(ja)
|
2018-12-20 |
2024-03-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヌクレアーゼ媒介リピート伸長
|
MX2021008291A
(es)
|
2019-01-17 |
2021-08-05 |
Regeneron Pharma |
Un modelo de roedor de trastornos del estado de animo.
|
WO2020152607A1
(en)
|
2019-01-22 |
2020-07-30 |
St. Jude Children's Research Hospital |
Modulation of lc3-associated endocytosis pathway and genetically modified non-human animals as a model of neuroinflammation and neurodegeneration
|
EP3927153A1
(en)
|
2019-02-22 |
2021-12-29 |
Regeneron Pharmaceuticals, Inc. |
Rodents having genetically modified sodium channels and methods of use thereof
|
WO2020190621A1
(en)
|
2019-03-15 |
2020-09-24 |
Regeneron Pharmaceuticals, Inc. |
A loss of function rodent model of solute carrier 39 member 5
|
US11737435B2
(en)
*
|
2019-04-04 |
2023-08-29 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized coagulation factor 12 locus
|
EP3969040A1
(en)
|
2019-05-13 |
2022-03-23 |
Regeneron Pharmaceuticals, Inc. |
Combination of pd-1 inhibitors and lag-3 inhibitors for enhanced efficacy in treating cancer
|
JP2022534867A
(ja)
|
2019-06-04 |
2022-08-04 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ベータスリップ変異を有するヒト化ttr遺伝子座を含む非ヒト動物と使用方法
|
BR112021023683A2
(pt)
|
2019-06-05 |
2022-02-01 |
Regeneron Pharma |
Roedor e camundongo geneticamente modificado, embrião de roedor, célula b do roedor ou camundongo geneticamente modificado, hibridoma, população de células b, célula-tronco embrionária, célula de mamífero, métodos de produção de um anticorpo, de uma cadeia pesada, de um domínio variável, de uma coleção de domínios variáveis, de uma cadeia leve, de uma sequência nucleotídica, de um roedor geneticamente modificado e de células es, de geração de um domínio variável e in vitro para gerar uma célula recombinante de roedor, e, vetor de direcionamento
|
AU2020289581A1
(en)
|
2019-06-07 |
2021-11-18 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized albumin locus
|
EA202192810A1
(ru)
|
2019-06-11 |
2022-03-05 |
Регенерон Фармасьютикалз, Инк. |
АНТИТЕЛА К PcrV, КОТОРЫЕ СВЯЗЫВАЮТ PcrV, КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТИТЕЛА К PcrV, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
CN114008193A
(zh)
|
2019-06-27 |
2022-02-01 |
瑞泽恩制药公司 |
Tdp-43蛋白病的建模
|
AU2020358847A1
(en)
|
2019-10-03 |
2022-04-21 |
Regeneron Pharmaceuticals, Inc. |
A Crnn loss of function rodent model
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
TW202140509A
(zh)
|
2019-12-13 |
2021-11-01 |
美商阿尼拉製藥公司 |
人類染色體9開讀框72(C9ORF72)iRNA劑組成物及其使用方法
|
WO2021154791A1
(en)
|
2020-01-28 |
2021-08-05 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized pnpla3 locus and methods of use
|
US20230081547A1
(en)
|
2020-02-07 |
2023-03-16 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized klkb1 locus and methods of use
|
EP4114173A1
(en)
|
2020-03-04 |
2023-01-11 |
Regeneron Pharmaceuticals, Inc. |
A rodent model of b4galt1-mediated functions
|
EP4125348A1
(en)
|
2020-03-23 |
2023-02-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
JP2023523174A
(ja)
|
2020-04-21 |
2023-06-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒト化cxcl13遺伝子を有する非ヒト動物
|
RU2751237C1
(ru)
*
|
2020-06-10 |
2021-07-12 |
Регенерон Фармасьютикалс, Инк. |
Способы и композиции для направленной модификации генома
|
EP4171215A2
(en)
|
2020-06-26 |
2023-05-03 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ace2 locus
|
IL301493A
(en)
|
2020-10-01 |
2023-05-01 |
Regeneron Pharma |
Rodent animals expressing human CR1
|
US20240065239A1
(en)
|
2020-12-16 |
2024-02-29 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing humanized fc alpha receptors
|
CN116802200A
(zh)
|
2020-12-21 |
2023-09-22 |
瑞泽恩制药公司 |
具有人源化tslp基因、人源化tslp受体基因和/或人源化il7ra基因的非人动物
|
BR112023018874A2
(pt)
|
2021-03-31 |
2023-10-03 |
Regeneron Pharma |
Camundongos geneticamente modificados compreendendo componentes do sistema imunológico celular humanizado com diversidade melhorada do repertório de tcrb
|
CA3231899A1
(en)
|
2021-11-04 |
2023-05-11 |
Trevor Stitt |
Non-human animals comprising a modified cacng1 locus
|
AU2022408167A1
(en)
|
2021-12-08 |
2024-06-06 |
Regeneron Pharmaceuticals, Inc. |
Mutant myocilin disease model and uses thereof
|
WO2023122506A1
(en)
|
2021-12-20 |
2023-06-29 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising humanized ace2 and tmprss loci
|
WO2023150798A1
(en)
|
2022-02-07 |
2023-08-10 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for defining optimal treatment timeframes in lysosomal disease
|
US20230257432A1
(en)
|
2022-02-11 |
2023-08-17 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for screening 4r tau targeting agents
|
WO2023212560A1
(en)
|
2022-04-26 |
2023-11-02 |
Regeneron Pharmaceuticals, Inc. |
A rodent model of fibrodysplasia ossificans progressiva
|
WO2023235677A1
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Animal model of tdp-43 proteinopathy
|
US20230417899A1
(en)
|
2022-06-27 |
2023-12-28 |
Oshkosh Corporation |
Position tracking for a lift device
|
WO2024020057A1
(en)
|
2022-07-19 |
2024-01-25 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified animal model and its use to model the human immune system
|
WO2024026488A2
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a modified transferrin receptor locus
|
WO2024031053A1
(en)
|
2022-08-05 |
2024-02-08 |
Regeneron Pharmaceuticals, Inc. |
Aggregation-resistant variants of tdp-43
|
WO2024064860A1
(en)
|
2022-09-22 |
2024-03-28 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified mice expressing components of human cellular immune system
|
WO2024073679A1
(en)
|
2022-09-29 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
|